Dr. Seolhyun Lee, MD

Dr. Lee practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Lee's NPI, 1588087142, was assigned on January 31, 2014. Dr. Lee graduated from Other in 2007. Dr. Lee holds California license C159407.

Dr. Lee's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Lee's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Lee is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Lee to 2 more hospitals and 2 medical groups, each named with a free account. Dr. Lee's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Lee is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Lee's licenses on file in 4 states: California, Washington, Georgia and New Jersey.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, electrolyte disorders, fluid and electrolyte imbalances, kidney disease and kidney failure among the conditions Dr. Lee treats.

CMS data shows 1,286 Medicare services from Dr. Lee across 11 procedure codes in 2024, for 423 Medicare patients. Medicare paid $124,690 for them.

CMS counts 423 Medicare patients who saw Dr. Lee in 2024. The largest group is 65 to 74, with 162 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 37% are also on Medicaid. Their average risk score is 3.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 61, with 42% women.

In 2024, Dr. Lee wrote 806 Medicare Part D claims for 145 patients. 83% of them were for generic drugs. CMS names the drug for 653 of them, across 23 drugs with 11 or more claims each, at $306,295 in total drug cost. In 2023, CMS named 410 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Lee for performance year 2024, reported as part of a group. Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lee as offering telehealth.

Dmand AI links 7 papers to Dr. Lee, published from 2021 to 2024. 2022 was the busiest year, with 2. The most frequent topics are Renal Dialysis, Charcoal and Dialysis Solutions. Dr. Lee has published most often in Clin J Am Soc Nephrol. Dr. Lee's most frequent co-authors are Timothy Meyer, MD, Tammy Lisa Sirich, MD and Saniya Bonde.

CMS Open Payments shows 12 general payments to Dr. Lee from 8 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 100% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $120.

Dr. Lee graduated from Other in 2007.

Dr. Lee is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.